Relation of age, gender, and bone mass to circulating sclerostin levels in women and men
Top Cited Papers
Open Access
- 18 August 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 26 (2), 373-379
- https://doi.org/10.1002/jbmr.217
Abstract
Sclerostin is a potent inhibitor of Wnt signaling and bone formation. However, there is currently no information on the relation of circulating sclerostin levels to age, gender, or bone mass in humans. Thus we measured serum sclerostin levels in a population-based sample of 362 women [123 premenopausal, 152 postmenopausal not on estrogen treatment (ET), and 87 postmenopausal on ET] and 318 men, aged 21 to 97 years. Sclerostin levels (mean ± SEM) were significantly higher in men than women (33.3 ± 1.0 pmol/L versus 23.7 ± 0.6 pmol/L, p < .001). In pre- and postmenopausal women not on ET combined (n = 275) as well as in men, sclerostin levels were positively associated with age (r = 0.52 and r = 0.64, respectively, p < .001 for both). Over life, serum sclerostin levels increased by 2.4- and 4.6-fold in the women and men, respectively. Moreover, for a given total-body bone mineral content, elderly subjects (age ≥ 60 years) had higher serum sclerostin levels than younger subjects (ages 20 to 39 years). Our data thus demonstrate that (1) men have higher serum sclerostin levels than women, (2) serum sclerostin levels increase markedly with age, and (3) compared with younger subjects, elderly individuals have higher serum sclerostin levels for a given amount of bone mass. Further studies are needed to define the cause of the age-related increase in serum sclerostin levels in humans as well as the potential role of this increase in mediating the known age-related impairment in bone formation. © 2011 American Society for Bone and Mineral Research.Keywords
This publication has 32 references indexed in Scilit:
- Regulation of circulating sclerostin levels by sex steroids in women and in menJournal of Bone and Mineral Research, 2010
- Serum Sclerostin Levels Negatively Correlate with Parathyroid Hormone Levels and Free Estrogen Index in Postmenopausal WomenJournal of Clinical Endocrinology & Metabolism, 2010
- Comparison of sex steroid measurements in men by immunoassay versus mass spectroscopy and relationships with cortical and trabecular volumetric bone mineral densityOsteoporosis International, 2008
- Regulation of bone mass by Wnt signalingJCI Insight, 2006
- Effects of Sex and Age on Bone Microstructure at the Ultradistal Radius: A Population-Based Noninvasive In Vivo AssessmentJournal of Bone and Mineral Research, 2006
- Sclerostin is a delayed secreted product of osteocytes that inhibits bone formationThe FASEB Journal, 2005
- Calibration of trabecular bone structure measurements of in vivo three-dimensional peripheral quantitative computed tomography with 28-μm-resolution microcomputed tomographyBone, 1999
- Morphometric analysis of noninvasively assessed bone biopsies: Comparison of high-resolution computed tomography and histologic sectionsBone, 1996
- Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss.JCI Insight, 1983
- Mean wall thickness of trabecular bone packets in the human iliac crest: Changes with ageCalcified Tissue International, 1978